Aaron Cowley

Dr. Aaron Cowley is the Chief Scientific Officer at Arranta Bio, having been a co-founder and the Chief Technical Officer of Captozyme, which served the microbiome CDMO market for 10 years since 2009 and merged with Arranta Bio in October 2019.

He is a renowned member of the biotech community and was the recipient of the prestigious Ruth L. Kirschstein National Research Service Award for his post-doctoral work at the University of Georgia. His further work has resulted in 15 peer-reviewed journal articles.

Prior to establishing Captozyme in 2009, Dr. Cowley was a Scientist II/Preclinical Manager at OxThera, Inc. in Alachua, Florida.

He holds a Bachelor’s Degree in Biochemistry from Benedictine College, a Ph.D in Inorganic Chemistry from the University of Kansas, and an MBA from the University of Florida.